Haris Babačić

About me
Publications
CV
Public outreach and news

About me

I am a postdoctoral researcher in cancer proteomics, with a particular interest in glioblastoma and plasma proteomics. I defended my PhD thesis at
the Karolinska Institute, titled "Discovering circulating protein biomarkers through in-depth plasma proteomics".

Overall, I have a profound interest in learning and combining biomedical research skills on the molecular, clinical, and epidemiological level, aiming to improve diagnostics and therapeutics of cancer. Methodologically, I am interested in proteomics, proteogenomics, research design, medical statistics, and bioinformatics.

Research

My current primary research focus is glioblastoma proteomics. We aim to discover protein biomarkers circulating in blood plasma, which can stratify glioblastoma patients with regards to treatment and prognosis. Broadly, I have an interest in cancer proteomics and precision medicine.

Teaching

Responsible for the course Omics Data Analysis: From Quantitative Data to Biological Information [1].
Teaching experimental design and data analysis, course Mass spectrometry-based proteomics: When and How [2].

[1] https://kiwas.ki.se/katalog/katalog/kurs/9726
[2] https://kiwas.ki.se/katalog/katalog/kurs/9724

Articles

Article: NATURE COMMUNICATIONS. 2023;14(1):5921

Comprehensive proteomics and meta-analysis of COVID-19 host response.

Babačić H; Christ W; Araújo JE; Mermelekas G; Sharma N; Tynell J; García M; Varnaite R; Asgeirsson H; Glans H; Lehtiö J; Gredmark-Russ S; Klingström J; Pernemalm M
Article: RESPIRATORY RESEARCH. 2023;24(1):62

Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia.

Palma Medina LM; Babačić H; Dzidic M; Parke Å; Garcia M; Maleki KT; Unge C; Lourda M; Kvedaraite E; Chen P; Muvva JR; Cornillet M; Emgård J; Moll K; Karolinska K. I./K. COVID-19 Study Group; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg K-J; Sandberg JK; Gredmark-Russ S; Rooyackers O; Svensson M; Chambers BJ; Eriksson LI; Pernemalm M; Björkström NK; Aleman S; Ljunggren H-G; Klingström J; Strålin K; Norrby-Teglund A
Article: MOLECULAR ONCOLOGY. 2023;17(2):238-260

Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.

Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
Article: NEOPLASIA. 2021;23(8):783-791

Plasma proteome alterations by MAPK inhibitors in BRAFV600-mutated metastatic cutaneous melanoma.

Babačić H; Eriksson H; Pernemalm M
Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2020;8(1):e000204

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma.

Babačić H; Lehtiö J; Pico de Coaña Y; Pernemalm M; Eriksson H
Article: JOURNAL OF NEUROLOGY. 2019;266(6):1358-1366

Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.

Montagnese F; Babačić H; Eichhorn P; Schoser B
Article: JOURNAL OF NEUROLOGY. 2019;266(1):133-147

Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.

Wenninger S; Greckl E; Babačić H; Stahl K; Schoser B
Article: JOURNAL OF NEUROMUSCULAR DISEASES. 2018;5(4):451-459

How to Interpret Abnormal Findings of Spirometry and Manometry in Myotonic Dystrophies?

Babačić H; Goldina O; Stahl K; Montagnese F; Jurinović V; Schoser B; Wenninger S
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2018;25:112-121

The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?

Barin L; Salmen A; Disanto G; Babačić H; Calabrese P; Chan A; Kamm CP; Kesselring J; Kuhle J; Gobbi C; Pot C; Puhan MA; von Wyl V; Swiss Multiple Sclerosis Registry (SMSR)
Article: NEUROMUSCULAR DISORDERS. 2018;28(3):229-235

Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey.

Jiménez-Moreno AC; Raaphorst J; Babačić H; Wood L; van Engelen B; Lochmüller H; Schoser B; Wenninger S

All other publications

Thesis / dissertation: 2023

Discovering circulating protein biomarkers through in-depth plasma proteomics

Babačić, Haris
Letter: ALLERGY. 2022;77(1):296-298

A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals.

Brnjarchevska Blazhevska T; Babačić H; Sibinovska O; Dobrevski B; Kirijas M; Milanovski G; Arsov T; Petlichkovski A
Preprint: MEDRXIV. 2020

Global between-countries variance in SARS-CoV-2 mortality is driven by reported prevalence, age distribution, and case detection rate

Babačić H; Lehtiö J; Pernemalm M
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):9574

Plasma proteomic analyses and treatment predictive biomarker candidates in melanoma patients receiving immune checkpoint blockade or targeted therapy.

Eriksson H; Babacic H; Lehtio J; Pernemalm M
Review: PLOS ONE. 2019;14(2):e0212198

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.

Babačić H; Mehta A; Merkel O; Schoser B

Employments

Postdoctoral Researcher, Department of Oncology-Pathology, Karolinska Institutet, 2023-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2023

About me

Research

Teaching

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI